Lung Squamous Cell Carcinoma — Trials

Lung Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

141 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 37
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 46%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05127590	RBN-2397 in Combination With Pembrolizumab in Patients With SCCL	unknown	Phase 1 / Phase 2	50	Ribon Therapeutics, Inc.INDUSTRY	4	Jul 3, 2023	clinicaltrials
NCT02583542	A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers(TORCMEK)	unknown	Phase 1 / Phase 2	118	Queen Mary University of LondonOTHER	1	Feb 25, 2020	clinicaltrials